Invention & Innovation in 3D Printing of Organs and Tissues
12th July 2021
Medical 3D Printing
Medical 3D Printing of Organs and Tissues
3D printing as a technique has been ground-breaking in the food industry, fashion industry, construction, education sector and biotechnology but how close is it to saving people’s lives? 3D printed organs and tissues has been a hot topic for years, but they are still not readily available to the public.
Our article, 3D Printing Organs and Tissues, looks at the investment and innovators driving this technology. Through a patent lens, we uncovered the following:
- Medical 3D Printing may be the answer to increasing organ shortages and will satisfy the demand for organ transplants
- Despite continued investment into medical 3D printing technology, regulatory and safety related challenges persist causing a plateauing pace of invention
- Revotek remains the global industry leader in 3D bioprinting space with 80% of their inventions protected in China
Insights & Events
21st Century Evolution of Sustainable Plastic Technology Trends
To mark World Environment Day, Cipher tracks sustainable plastics technology innovators and owners in the 21st century.
Read more
The increasing importance of IP
How intellectual property (IP) moved into the business mainstream, as seen from the perspective of guests on the Cipher Vision Podcast.
Read more
Game Over for the West?
Our report looking at patent owners of gaming technology found that Japanese firms dominated but it also uncovered some unexpected trends.
Read more
Could NPEs stifle innovation in sustainable energy?
Patents owned by sustainable energy organisations may be at risk from NPEs, which could stifle any innovation and development of technologies in this area.
Read more
LOT Network Report 2022
The 2022 report, produced for the organisation by Cipher, highlights that none of the assets which have left LOT Network have been used against its members.
Read more
Cipher is now part of LexisNexis Intellectual Property
Update: We are pleased to announce that the customary regulatory clearances have been received and the acquisition has officially closed.
Read more
With Cipher you can…
Optimise your portfolio
Ensure you have the right portfolio to meet your strategic patenting objectives.
Gather competitor intelligence
Understand who’s doing what by automating patent to technology mapping.
Model cross licensing
Combine patent and revenue data to determine rational licensing outcomes.
Manage your budget
Justify patent budgets and communicate the impact of your investment.
Conduct due diligence
Automate manual reviews for efficient execution of M&A and licensing transactions.
Tackle inbound patent assertion
Be prepared with evidence to create a fast and effective threat assessment.
Benchmark your portfolio
Assess your portfolio in comparison to other owners through your technology lens.
Monetise your portfolio
Identify opportunities to create value through licensing or sale of patent assets.
Predict technology trends
Track new technologies and discover the unknown owners of future innovation.
Create Risk Mitigation Strategies
Understand the materiality of your threats to define your risk mitigation strategy.